Related Experiment Video
Updated: Sep 27, 2025

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders.
Anupam Rej1, Michael D E Potter2, Nicholas J Talley2
1Academic Unit of Gastroenterology, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, England.
Diet significantly impacts small bowel disorders like nonceliac gluten/wheat sensitivity, eosinophilic gastroenteritis, and small intestinal bacterial overgrowth. Dietary interventions show promise but require further research for effective management.
Area of Science:
- Gastroenterology
- Nutrition Science
- Microbiology
Background:
- Diet is increasingly recognized for its role in small bowel disorders.
- Three primary conditions with potential dietary interventions include nonceliac gluten/wheat sensitivity, eosinophilic gastroenteritis, and small intestinal bacterial overgrowth.
- Current diagnostic and therapeutic strategies for these conditions present challenges and knowledge gaps.
Purpose of the Study:
- To review the current understanding of dietary interventions in small bowel disorders.
- To highlight the role of diet in nonceliac gluten/wheat sensitivity, eosinophilic gastroenteritis, and small intestinal bacterial overgrowth.
- To identify areas for future research and clinical advancement.
Main Methods:
- Literature review focusing on dietary interventions for small bowel conditions.
- Analysis of current research on triggers, diagnostics, and treatments.
- Synthesis of findings to provide an overview of the field.
Main Results:
- Nonceliac gluten/wheat sensitivity may involve triggers beyond gluten, with gluten-free diets as a primary treatment, though adherence and duration are debated.
- Dietary interventions like elimination and elemental diets show potential for eosinophilic gastroenteritis, necessitating further trials.
- Diet's role in small intestinal bacterial overgrowth (SIBO) is under investigation, but current management primarily relies on antimicrobials due to diagnostic limitations.
Conclusions:
- Dietary interventions represent a novel and advancing field for managing small bowel disorders.
- Further robust clinical trials are essential to validate and refine dietary approaches.
- Improved diagnostic tools and a deeper understanding of microbial-diet interactions are needed for SIBO.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

